This study showed that there was no relationship between glutathione S-transferase polymorphisms and prostate cancer in the analyzed group of patients, which makes our results different from those obtained in previous studies on the role of these genetic variants in cancer etiology. Here, HPGDS is linked to prostate carcinoma.